Haemonetics Reports Q2 Adjusted Earnings per Share of $0.80

Haemonetics Corporation HAE today reported GAAP net revenues of $166.8 million, up 6%, net income of $21.3 million, up 18%, and earnings per share of $0.85, up 23%. Excluding transformation costs and contingent consideration income in fiscal 11, adjusted second quarter net income was $20.1 million, up 11%, and adjusted earnings per share was $0.80, up 16%. In constant currency, revenue was up 7%, adjusted net income was up 12% and adjusted earnings per share were up 16%. (1) Year to date, Haemonetics reported GAAP net revenues of $330 million, up 6%, net income of $39.3 million, up 9%, and earnings per share of $1.54, up 12%. Excluding transformation costs and contingent consideration income in fiscal 11, adjusted year to date net income was $39.1 million, up 8%, and adjusted earnings per share was $1.54, up 12%. In constant currency, revenue was up 7%, adjusted net income was up 20% and adjusted earnings per share were up 23%.